170 related articles for article (PubMed ID: 2140607)
1. Discriminative stimulus properties of flesinoxan.
Ybema CE; Slangen JL; Olivier B; Mos J
Pharmacol Biochem Behav; 1990 Apr; 35(4):781-4. PubMed ID: 2140607
[TBL] [Abstract][Full Text] [Related]
2. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
Glennon RA
Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
Dreteler GH; Wouters W; Saxena PR
Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus properties of the serotonergic compound eltoprazine.
Ybema CE; Slangen JL; Olivier B; Mos J
J Pharmacol Exp Ther; 1992 Mar; 260(3):1045-51. PubMed ID: 1532031
[TBL] [Abstract][Full Text] [Related]
6. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
[TBL] [Abstract][Full Text] [Related]
7. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
[TBL] [Abstract][Full Text] [Related]
8. Generalization of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and ipsapirone to yohimbine.
Winter JC
Pharmacol Biochem Behav; 1988 Jan; 29(1):193-5. PubMed ID: 2895479
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus properties of the 5-HT1A receptor biased agonists NLX-101 and F13714, in rats trained to discriminate 8-OH-DPAT from saline.
Broadbear JH; Depoortere RY; Vacy K; Ralph D; Tunstall BJ; Newman-Tancredi A
Behav Pharmacol; 2021 Dec; 32(8):652-659. PubMed ID: 34751175
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of 8-OH-DPAT in rats are not altered by pretreatment with para-chlorophenylalanine.
Kalkman HO
Psychopharmacology (Berl); 1990; 101(1):39-42. PubMed ID: 1971447
[TBL] [Abstract][Full Text] [Related]
11. Systemic and regional hemodynamic effects of the 5-hydroxytryptamine1A receptor agonists flesinoxan and 8-hydroxy-2(di-N-propylamino)tetralin in the conscious rat.
Dreteler GH; Wouters W; Toorop GP; Jansen JA; Saxena PR
J Cardiovasc Pharmacol; 1991 Mar; 17(3):488-93. PubMed ID: 1711612
[TBL] [Abstract][Full Text] [Related]
12. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
[TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus properties of flesinoxan: effects of enantiomers, (S)-UH301 and WAY-100635.
Gommans J; Hijzen TH; Maes RA; Mos J; Olivier B
Eur J Pharmacol; 1995 Sep; 284(1-2):135-40. PubMed ID: 8549617
[TBL] [Abstract][Full Text] [Related]
14. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery.
Parsons AA; Motevalian M; Whalley ET
Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803
[TBL] [Abstract][Full Text] [Related]
15. The discriminative stimulus properties of buspirone involve dopamine-2 receptor antagonist activity.
Rijnders HJ; Slangen JL
Psychopharmacology (Berl); 1993; 111(1):55-61. PubMed ID: 7870934
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus properties of eltoprazine in the pigeon.
Olivier B; Herremans A; Mos J; van Drimmelen M; Tulp M; van Oorschot R; Hijzen T
Pharmacol Biochem Behav; 1999 Oct; 64(2):421-7. PubMed ID: 10515324
[TBL] [Abstract][Full Text] [Related]
18. Involvement of 5-HT1A activity in the discriminative stimulus effects of imipramine.
Barrett JE; Zhang L
Pharmacol Biochem Behav; 1991 Feb; 38(2):407-10. PubMed ID: 1829231
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus effects of 8-hydroxy-2-(di-n-propylamino)tetralin in pigeons and rats: species similarities and differences.
Kleven MS; Koek W
J Pharmacol Exp Ther; 1998 Jan; 284(1):238-49. PubMed ID: 9435184
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic studies on DOM as a discriminative stimulus.
Glennon RA; Hauck AE
Pharmacol Biochem Behav; 1985 Dec; 23(6):937-41. PubMed ID: 2934750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
